Page last updated: 2024-08-23

epirubicin and Signet Ring Cell Carcinoma

epirubicin has been researched along with Signet Ring Cell Carcinoma in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adenis, A; Christophe, V; Di Fiore, F; Guilbert, M; Le Malicot, K; Mariette, C; Messager, M; Moreau, M; Piessen, G; Robb, WB	1
Ebert, M; Grenacher, L; Lordick, F; Moehler, M; Röcken, C; Schumacher, G	1
Ishimura, H; Kajihara, S; Koie, T; Kudoh, S; Suzuki, T; Yoneyama, T	1

Reviews

1 review(s) available for epirubicin and Signet Ring Cell Carcinoma

Article	Year
[Diagnosis and treatment of gastric cancer]. Deutsche medizinische Wochenschrift (1946), 2010, Volume: 135, Issue:34-35 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Signet Ring Cell; Cisplatin; Endoscopy, Digestive System; Epirubicin; Esophagectomy; Fluorouracil; Gastrectomy; Gastric Mucosa; Humans; Laparoscopy; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Neoplasm, Residual; Stomach Neoplasms; Tomography, X-Ray Computed	2010

Article

Year

[Diagnosis and treatment of gastric cancer].

Deutsche medizinische Wochenschrift (1946), 2010, Volume: 135, Issue:34-35

Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Signet Ring Cell; Cisplatin; Endoscopy, Digestive System; Epirubicin; Esophagectomy; Fluorouracil; Gastrectomy; Gastric Mucosa; Humans; Laparoscopy; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Neoplasm, Residual; Stomach Neoplasms; Tomography, X-Ray Computed

2010

Trials

1 trial(s) available for epirubicin and Signet Ring Cell Carcinoma

Article	Year
Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas - PRODIGE 19 - FFCD1103 - ADCI002. BMC cancer, 2013, Jun-10, Volume: 13 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; Cisplatin; Digestive System Surgical Procedures; Epirubicin; Fluorouracil; Humans; Research Design; Stomach Neoplasms	2013

Article

Year

Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas - PRODIGE 19 - FFCD1103 - ADCI002.

BMC cancer, 2013, Jun-10, Volume: 13

Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; Cisplatin; Digestive System Surgical Procedures; Epirubicin; Fluorouracil; Humans; Research Design; Stomach Neoplasms

2013

Other Studies

1 other study(ies) available for epirubicin and Signet Ring Cell Carcinoma

Article	Year
[Signet ring cell carcinoma of the urinary bladder: a case report]. Hinyokika kiyo. Acta urologica Japonica, 2004, Volume: 50, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Epirubicin; Humans; Male; Methotrexate; Neoplasm Staging; Treatment Outcome; Ureterostomy; Urinary Bladder Neoplasms; Urinary Diversion; Vinblastine	2004

Article

Year

[Signet ring cell carcinoma of the urinary bladder: a case report].

Hinyokika kiyo. Acta urologica Japonica, 2004, Volume: 50, Issue:2

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Epirubicin; Humans; Male; Methotrexate; Neoplasm Staging; Treatment Outcome; Ureterostomy; Urinary Bladder Neoplasms; Urinary Diversion; Vinblastine

2004